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As global pig health diseases, porcine respiratory disease complex (PRDC) and porcine 
circovirus-associated disease (PCVAD) generate substantial economic losses despite 
pigs been vaccinated against the primary causative virus, highlighting the importance 
of understanding virome interactions and specifically co-factor infections. Established 
primary endemic pathogens for PRDC include porcine circovirus 2 (PCV2), porcine 
reproductive and respiratory syndrome virus (PRRSv) and swine influenza virus (SIV), 
and PCV2 aetiology in interaction with other co-infecting viruses can result in PCVAD. 
Porcine parvovirus (PPV) 1 is a well-characterized virus with an available vaccine pre-
venting reproductive failure in sows. However, whilst novel PPV 2 to 7 viruses have been 
identified since 2001, their viral pathogenic potential in clinical and subclinical disease 
remains to be determined. Therefore, this study has sought to develop a better under-
standing of their potential role as associated co-infections in PRDC and PCVAD by ex-
amining archival samples for the presence of PCV2 and the novel parvoviruses PPV2-4 
from clinically diseased pigs across production age stages. Epidemiologically, the novel 
PPV2 was found to be the most prevalent within the fattener age group with PPV2-4 
statistically associated with pig respiratory disease and enteric ulcers. Additionally, sta-
tistical modelling by latent class analysis (LCA) on veterinary pathology scored pigs found 
a clustering co-factor association between PPV2 and PCV2, suggesting the novel PPV 
may be involved in PRDC and PCVAD. Phylogenetic analysis of novel PPVs revealed the 
PPV2 capsid evolution to be diverged from the original strains with a low nucleotide ho-
mology of 88%–96% between two distinct clades. These findings determine that novel 
PPV 2–4 viruses are statistically associated as co-infectors in a diseased pig population, 
and significantly detected PPV2 clustering co-infection frequency with PCV2 in PRDC 
and PCVAD diseased pigs through LCA analysis.
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1  | INTRODUC TION
The novel porcine parvoviruses (PPV2-PPV4) are emerging viral 
agents and globally endemic in domestic pig and wild boar popu-
lations (Afolabi et al., 2018; Cadar, Csagola, et al., 2013; Cságola 
et al., 2012; Huang et al., 2010; Zhang et al., 2014). Evidence of 
emerging PPV association with clinical disease has been broadly 
reported (Xiao, Gerber, et al., 2013; Opriessnig et al., 2014; 
Saekhow & Ikeda, 2014). However, as these single-stranded (ss) 
DNA novel viruses are not cell culture adapted, experimental in-
fection has been hindered, resulting in limited knowledge of viral 
pathogenesis or the relevance of these viruses both clinically 
and economically. Porcine circovirus type 2 (PCV2), a ssDNA 
virus, is the known causative agent of the multi-factorial disease, 
post-weaning multisystemic wasting syndrome (PMWS) in pigs 
(Allan et al., 1999; Segales, 2012). PCV2 disease is facilitated by 
a co-factor infection suppressing the pig immune system allowing 
PCV2 to replicate to a higher rate. Since the initial characterization 
of PMWS, further disease associations have been documented 
and referred to as PCV2-associated disease (PCVAD) to encom-
pass a wide variety of clinical symptoms and pathologies includ-
ing enteric, respiratory, porcine dermatitis nephropathy syndrome 
(PDNS) and reproductive and congenital disorders (Opriessnig 
et al., 2007). Additionally, a multi-factorial disease was recognized 
as porcine respiratory disease complex (PRDC) and is observed in 
pig herds where respiratory symptoms with coughing, fever, an-
orexia and gastric ulcers occur in recently weaned piglets and in 
older pigs. PRDC can be attributed to a wide range of viruses such 
as PCV2 and potentially PCV type 3 (Kedkovid et al., 2018), PRRSv 
and swine influenza virus (SIV) which is known to cause significant 
damage to the epithelial respiratory airways where secondary bac-
terial pathogens can then cause infection (Opriessnig et al., 2011). 
A next-generation sequencing (NGS) study on PRDC porcine lung 
samples has associated the presence of PPV2, PPV3, PPV6 and 
torque teno virus to PRDC diseased pigs (Qin et al., 2018).
The novel porcine parvoviruses PPV2-4 may have emerged ap-
proximately seventy years ago and possess a high nucleotide sub-
stitution rate similar to RNA viruses (Cadar, Lorincz, et al., 2013). 
Through frequent recombination, the positive selection of porcine 
parvoviruses has the capacity to further adapt and circulate amongst 
pig herds, which merits continuous phylogenetic mapping and the 
monitoring of disease association. PPV1 is considered an endemic 
virus in pig herds causing enteritis and dermatitis with gilts rou-
tinely vaccinated to prevent the vertically transmitted disorder, 
SMEDI (stillbirth, mummification, embryonic death and infertil-
ity) (Cartwright et al., 1969; Dea et al., 1985; Duhamel et al., 1991; 
Kresse et al., 1985; Mengeling et al., 2000).
PPV2, the earliest novel PPV, was discovered in 2001 during 
a hepatitis E virus porcine sera study (Hijikata et al., 2001). 
Subsequently in 2006, a South Eastern China study revealed a more 
divergent PPV2 strain (CN Strain) originating from archival samples 
from pigs with clinical symptoms of 'high fever disease' (Wang et al., 
2010). Phylogenetically, PPV3 is more closely related to PPV2 (Xiao, 
Gerber, et al., 2013) and was initially reported in 2007 from pig sam-
ples collected in Hong Kong (Lau et al., 2008). PPV4 which has three 
ORFs, similar to the genus bocaparvovirus, was initially identified in 
2010 (Cheung et al., 2010) in lung lavage samples (collected in 2005) 
of wasting pigs during a PCVAD outbreak in North Carolina (Cheung 
et al., 2007). PPV5 was discovered in the USA in 2013 and PPV6 in 
China in 2014 (Ni et al., 2014), and is both identified as closely re-
lated to PPV4 although the genomes lack the additional ORF3 found 
in PPV4 (Xiao, Gimenez-Lirola, et al., 2013). More recently, PPV7 
was discovered in 2016 by next-generation sequencing (NGS), a di-
vergent Parvoviridae linage, most closely related to turkey parvovi-
rus and Eidolon helvum parvovirus 2 was classified in the proposed 
genus Chapparvovirus (Palinski et al., 2016).
The current study sought to investigate the potential statistical 
association of the novel PPVs 2–4 with PCV2, the causative agent 
of PMWS. This was performed through a retrospective prevalence 
study of the pathological, molecular and phylogenetic analyses of 
PPV2-4 across different pig production age groups. Clinically, dis-
eased pigs’ samples over the period from 1997 to 2012 (either side 
of the introduction of the PCV2 vaccine in ~2006) with scored vet-
erinary pathology and tested for the presence of PPV2-4 and PCV2 
were analysed by LCA statistical modelling. This analysis revealed 
a clustering statistical association of PPV2 with PCV2 in diseased 
cohort of pigs with PCVAD and PRDC.
2  | METHOD
2.1 | Samples
A biobank of archival pig samples (n = 695), originating from 
Northern Ireland, Republic of Ireland, Great Britain and other neigh-
bouring European countries, sourced from 9 different studies and 
post-mortem submissions (Table S1), dating from 1997 to 2012, was 
collated. This cohort represented a single sample per animal, com-
prising of various sample types including lymph tissue, sera, abor-
tion fluid, abortion tissue, organ tissue, nasal swab and faeces (Table 
S1). Novel PPVs 2–4 are known to be endemic in 'healthy pigs', and 
as it is difficult to assess subclinical disease in pig herds, ultimately 
this study focused on clinically diseased pigs to demonstrate the 
prevalence and statistical association within this grouping (Streck 
et al., 2013). The PCV2 vaccine introduced in ~2006 reduces PCV2 
viraemia and viral shedding, and 65% of the samples from this study 
were categorized in the pre-vaccine category. These samples were 
sourced from veterinary diagnosed clinically diseased pigs repre-
senting production groups originating from France (n = 337, 48.5%), 
Northern Ireland (n = 182, 26.19%), Great Britain (n = 106, 15.25%), 
Republic of Ireland (n = 47, 6.7%) and Belgium (n = 23, 3.3%). All 
recorded sample data were reviewed, and where possible, included 
the history of animal, age, post-mortem veterinary gross pathology, 
diagnostic tests including PRRS and PCV2 indirect fluorescence 
assay, and veterinary histopathology. The collated sample data 
were categorized by production age groups as foetus (0 weeks), 
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pre-weaners (<4 weeks), weaners (>4 weeks to < 10 weeks) and fat-
teners (>10 weeks).
Samples were processed before nucleic acid extraction. Sera 
were removed from whole clotted blood and spun at 200 ×g for 
10 mins to pellet remaining blood cells. 10% w/v faecal samples 
were prepared in transport media with three freeze-thawed cycles 
and spun at 200 ×g for 30 mins 4°C to clarify the supernatant. 0.2 g 
of tissue samples was trimmed of fatty tissue and homogenized be-
fore clarifying at 200 ×g for 30 mins 4°C (TissueLyser ll, Qiagen Ltd, 
Crawley, UK). A 200 µl volume of processed sample was extracted 
by a Total Nucleic Acid kit on a MagNa Pure LC automated liquid 
handling platform (Roche, Burgess Hill, UK) alongside positive and 
negative controls.
2.2 | Detection PCR and sequencing
The detection of PCV2 and the PPVs (PPV1, PPV2, PPV3 and PPV4) 
(Eurofins, MWG Operon, Germany) (Table S4), primers were used at 
a concentration of 0.5 µM, in separate 25 µl qPCRs of QuantiTect 
SYBR® Green (Qiagen Ltd, Crawley, UK) with 2 µl sample template 
of nucleic acid. Samples were run in duplicate with an in-house PCR 
inter-run and the extraction controls on the LightCycler 480 (Roche, 
Burgess Hill, UK) with approximately 10% of samples tested for PPV1. 
PCR amplification of 45 cycles began after a 15-min activation step, 
followed by 95°C for 30 s, annealing 30 s (temperature was primer 
dependent see Table S4), extension at 72°C 30 s with a melt curve be-
fore cooling to 40°C. The sample PCR melt–curve analysis was com-
pleted with crossing threshold (Ct) >40 considered negative and Ct 
levels classified into low, medium and high levels (Table S1). The semi-
quantitative qPCR data from this study were restrictive as viral loads 
were not standardized by quantifying in copies per gram and PCR as-
says were of different specificity and sensitivity. PCR Ct values were 
accordingly scored as positive or negative for statistical purposes.
Sequencing primer sets were applied (Table S4) to selected sam-
ples with a low Ct to amplify the capsid gene. Specifically, the partial 
variable region of PPV2 VP1 capsid gene and the full VP capsid gene 
for PPV3 and PPV4 was amplified for phylogenetic analysis. Excised 
positive amplicons were purified through the Wizard® SV gel and 
PCR clean-up system (Promega, UK) and sequenced at Eurofins 
(MWG Operon, Germany). PCV2-positive samples open reading 
frame 2 from pre- and post-PCV2 vaccination samples (n = 50) were 
also sequenced (Collins & Zaykalova, 2020).
2.3 | Phylogenetic analysis
Multiple sequence alignments (MSA) of novel PPVs were generated 
using sequences available from Nucleotide-NCBI (National Centre 
for Biotechnology Information) and sequencing data analysed on 
Geneious 10v (Biomatters Ltd, Auckland, New Zealand). Sequenced 
amplicons of the novel PPVs whole and partial capsid were initially 
aligned on Geneious and then transferred and completed on Mega X 
(Mega software version 10.0.4) to avail of the alignment tool, multiple 
sequence comparison by log-expectation (MUSCLE) and phylogenetic 
tree builder through maximum-likelihood (ML) phylogenetic trees ob-
taining 1,000 bootstrap replicates. Phylogenetic trees were graphically 
viewed and edited in Interactive Tree of Life (Letunic & Bork, 2016).
2.4 | Statistical analysis
Initial statistical analysis from the whole cohort of samples evalu-
ated possible association between the detection of virus and disease 
was completed using permutation tests to calculate the significance 
probability for the classical chi-square test of the independence of 
rows and columns in a two-dimensional contingency table using 
GenStat 16.2 (2013) (VSN International Ltd) (Roff & Bentzen, 1989). 
All collated results from clinical observations such as wasting, gross 
pathology, histopathology, diagnostic immunofluorescent assay 
(IFA) and PCR findings were presented in a scored matrix with posi-
tives “1”, negatives “0” and no information as a “blank”. Chi-squared 
uni-variate analysis was set with the probability value “P” at the sta-
tistical significance level of .05.
2.5 | Latent class analysis
LCA was completed using the poLCA package in R (Linzer & 
Lewis, 2011), which allows for both traditional LCA and latent class 
regression, where the probability of being in one or another class 
is influenced by other covariates besides those used to define the 
classes (Dayton & Macready, 1988). Only UK and Ireland samples 
for which symptoms were recorded (n = 272) were included in these 
analyses (Supplementary Data S2). Models were run from 200 or 
400 random starting points to ensure, as far as possible, that the 
final fit is a global maximum. A key question for LCA is how many 
latent classes are present. This was decided by a combination of ad-
vice from veterinary experts, who reviewed the sets of symptoms 
included in analysis, and for the resulting classes, the Bayesian infor-
mation criterion (BIC) (Dziak et al., 2012) (Supplementary Data S2). 
As with any other analysis, there is a risk of false-negative and false-
positive classifications with LCA, but this is mitigated to the extent 
possible, by the principled examination of a range of models, and use 
of expert domain knowledge to guide model construction. All of the 
models considered are presented in Supplementary Data S2.
3  | RESULTS
3.1 | Viral prevalence by age group and year
PCV2 was determined to be the most frequently detected virus 
48% (331/695) across all age groups examined in this study, fol-
lowed by PPV2 17.3% (120/695) (Figure 1 and Table S3). In foetuses, 
PCV2 prevalence was 36% (51/143), PPV2 2.8% (4/143), PPV4 0.7% 
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(1/143) whilst PPV3 was not detected. A similar pattern was also 
observed in both the pre-weaner and weaner age groups, indicating 
an increase in PCV2 prevalence from 22% (40/182) to 61% (77/127), 
respectively, with no major increase in the prevalence of other novel 
PPVs. Only within the fattener age group did novel parvovirus's 
prevalence increase to higher levels with PPV2 at 56% (84/150), 
PPV3 14% (21/150) and PPV4 at 9% (13/150), although PCV2 re-
mained the most frequently detected virus at 77% (115/150).
The profiling of PCV2 detection from 1997 to 2012 found PCV2 
consistently present in all years from 1998; however, a decline in 
viral presence was recorded when the vaccine introduction (~2006) 
occurred (Table 1, Figure S5). Interestingly, the PCV2 levels also pro-
filed an increased frequency, per year, post-PCV2 vaccine introduc-
tion. The earliest detection of co-infections of the novel PPV’s was 
PPV2 in 1998, whilst PPV3 and PPV4 were first detected in 2000 
(Table 1). The novel PPVs were detected in samples prior to their ini-
tial discovery dates although a study did also detect PPV2 and PPV3 
in the USA in 1998 (Opriessnig et al., 2014). A PPV2 sample, not cap-
tured in this data analysis, was sequenced from 1996 and included 
in the phylogenetic analysis. The PPV4 from this study detected in 
2000 is the earliest reported PPV4.
3.2 | Viral tissue tropism
In clinically diseased pigs, PCV2 was the most frequently de-
tected virus 48% (331/695) prevalence), followed by PPV2 at 17% 
(120/695). PPV3 and PPV4 were only detected at a low prevalence 
of 6% (40/695) and 3% (24/695), respectively (Figure 2 and Table S3). 
Foetuses and abortion juice tested positive for novel PPVs at a lower 
prevalence, with only three samples testing positive for PPV2 and 
one for PPV4. The known vertically transmitted PCV2 virus was pre-
sent in 24% (21/88) of abortion juice samples and in 53% (16/30) of 
foetus samples, and although only one placenta sample was tested, 
it was positive only for PPV2. No PPV2-PPV4 were present in colon, 
small intestine, thymus and brain samples although these were rep-
resentative of low sample numbers.
Lymphatic tissue and lymph nodes (LN) were screened for the 
novel viruses, reporting PPV2, PPV3 and PPV4 prevalence in spleen 
at 43% (13/30), 3% (1/30) and 7% (2/30), respectively, tonsils at 28% 
(5/18), 17% (3/18) and 6% (1/18), mesenteric LN at 30% (33/109), 
11% (12/109) and 4%, (4/109) and inguinal LN at 52% (31/60), 7% 
(4/60) and 5% (3/60). Interestingly, PPV2 was the only novel PPV 
detected in a small subset of bronchial LNs at 33% (1/3) and medi-
astinal LNs at 29% (2/7) prevalence. All novel PPVs were present in 
the lungs, with PPV2 having the highest prevalence of 30% (15/50), 
comparable to the prevalence of PCV2 at 48% (24/50), with PPV3 
and PPV4 been detected less frequently at 6% (3/50) and 8% (4/50) 
prevalence. Nasal swabs provided for a lower detection rate of PPV2 
at 2% (1/52), PPV3 at 6% (3/52), PPV4 at 2% (1/52) and PCV2 at 17% 
(9/52). Sera and faecal samples were positive for PCV2 and the novel 
PPVs; however, sera had the highest prevalence of PCV2 at 30% 
(58/193), PPV2 at 6% (12/193), PPV3 at 6% (11/193) and PPV4 at 3% 
F I G U R E  1   Age vs virus prevalence. 
The prevalence of PCV2 and PPV2-4 
viruses in various sample types from 
pig production age groups, detected 
PCV2 (77%) and PPV2 (56%) as the most 
prevalent in the fattener age group. PPV2-
3 prevalence was observed at low levels of 
prevalence across the foetus, pre-weaner 
and weaner age groups, suggesting there 
was no vertical transmission or there is 
maternal antibody protection
TA B L E  1   Virus prevalence per year
Year
n = total 
samples PCV2 PPV2 PPV3 PPV4
1997 1 0 0 0 0
1998 3 3 (100%) 2 (67%) 0 0
2000 11 6 (55%) 0 3 (27%) 4 (36%)
2001 8 7 (88%) 0 0 0
2002 25 22 (88%) 14 (56%) 5 (20%) 2 (8%)
2003 2 2 (100%) 0 0 0
2004 135 128 (95%) 41 (30%) 5 (4%) 5 (4%)
2005 16 15 (94%) 3 (19%) 0 0
2006 3 3 (100%) 0 0 0
2008 20 2 (10%) 0 0 0
2009 208 45 (22%) 8 (4%) 5 (2%) 0
2010 219 77 (35%) 39 (18%) 21 
(10%)
8 (4%)
2011 19 4 (21%) 3 (16%) 1 (5%) 2 (11%)
2012 25 17 (68%) 10 (40%) 0 3 (12%)
Total 695 331 120 40 24
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(6/193). Concurrent infections did occur in clinically diseased pigs, 
with dual infection of PCV2 and novel PPV2 being most frequent 
at 12.9% (Table 2). PCV2 dual infection with PPV3 only occurred 
in 3.6% of samples, and PPV2 and PPV3 concurrent infection rates 
were similar (3%), with all other dual or multiple infections occurring 
in less than 3% of cases (Table 2 and 3).
3.3 | Viral presence and statistical associations with 
clinical and pathological observations
A total of 25 different parameters including gross post-mortem ob-
servations, pathological/histopathological findings and the results 
of diagnostic assays (such as the IFA for PRRSv) were used as a scor-
ing matrix of clinically diseased pigs (Table 4). The data set (n = 695 
samples) was initially subjected to chi-squared analysis in order to 
investigate the presence of virus and statistical association with 
clinical and pathological presentations. A significant association of 
virus and lung pathologies was observed for PCV2 (p = .012), PPV2 
(p = .001) and PPV4 (p = .01). PCV2 was significantly linked to res-
piratory pathogenesis with respiratory symptoms (p = .012), pneu-
monia (p = .017) and broncho interstitial pneumonia (BIP) (p = .036). 
PPV2 also showed significance to the same respiratory pathogen-
esis parameters but with an additional pathogenesis of lung oedema 
and at greater statistical significance (p = .001). Notably, PPV3 pre-
sented no association with respiratory pathogenesis, and PPV4 had 
only significant association to pathogenesis and lung oedema. PCV2 
was the only virus to demonstrate statistical significance (p = .001) 
with wasting symptoms, enlarged lymph nodes, lymphoid depletion 
and intracellular inclusions. PPV3 and PPV2 provided none of these 
F I G U R E  2   Prevalence of virus per tissue. The tissue tropism of PCV2 and PPV2-PPV4 viruses was detected in clinically diseased pigs. 
PCV2 was systemic and detected in most tissue types (47%), the novel parvoviruses were detected at lower levels of PPV2 (17%), PPV3 
(5.8%) and PPV4 (3.5%)
TA B L E  2   Concurrent infections






PPV2 90 (12.9%) 120 (17.2%)
PPV3 25 (3.6%) 23 (3%) 40 (5.8%)
PPV4 20 (2.88%) 8 (1.2%) 4 (0.6%) 24 (3.5%)
TA B L E  3   Multiple concurrent infections
Virus n (%)
PCV2, PPV2, PPV3 17 (2.4%)
PCV2, PPV2, PPV3, PPV4 1 (0.14%)
PCV2, PPV3, PPV4 2 (0.29%)
PPV2, PPV3, PPV4 1 (0.14%)
6  |     LAGAN TREGASKIS ET AL.
associations but PPV2 was statistically associated with lymphoe-
dema (p = .002) with PPV4 also significantly associated with lym-
phoedema and intracellular inclusions (p = .001). In addition, PPV2 
and PPV3 were also significantly associated with peritonitis and all 
novel PPVs were statistically associated with ulcers detected in the 
stomach, colon and caecum (p = .001 to p = .004). Kidney disease 
had the most significant association with PPV4 (p = .001), and PPV2 
was less (p = .038), whereas PCV2 and PPV3 had no association. 
Porcine dermatitis and nephropathy syndrome (PDNS) were only as-
sociated with PPV2 (p = .001) and PPV3 (p = .017) and interestingly 
none with PCV2. The novel systemic PPVs and specifically PPV2, 
statistical analysis reveals, significant association to a range of clini-
cal disease and pathologies; however, these associations are unable 
to infer the PPV’s causal role in the associated pathogenesis.
3.4 | Latent class analysis
Viral co-infections were examined using logistic regression 
analysis and graphical 95% confidence interval level (Table 5 & 
Supplementary Data S2) and the clinical signs and pathologies 
plotted (Figure 3 and Supplementary Data S2). The frequency of 
clinical signs varied greatly, with, for example, enteric pathologies 
being recorded over 125 times whereas symptoms such as men-
ingitis and rash were rarely seen across four studies (Figure 3). 
Data were excluded where animals had no clinical or pathologi-
cal data recorded, whilst animals on which data were recorded 
were included, even if the data were recorded with the absence 
of a symptom, sign or finding. An important question addressed 
as part of the analysis was the choice of symptoms to include and 
the number of latent classes to be identified. There are 25 differ-
ent symptoms reported, and the use of low-frequency symptoms 
is expected to be uninformative. To address these, each LCA model 
was run on the six symptoms occurring 50 times or more, the 14 
symptoms occurring 20 times or more, and the 22 symptoms oc-
curring 10 times or more, as well as all 25 symptoms. Each model 
was fit to between 1 and 6 latent classes, and these models were 
then reviewed, both to see whether there were major substantive 
differences between them, and, by veterinary experts, based on 
the clustering of clinical pathologies. For most models, the lowest 
Symptom Present Absent Total
Per 
cent
Wasting 61 149 210 29
Porcine respiratory and reproductive 
syndrome virus antibody by IFA (PRRS Ab)
4 206 210 1.90
Lymphoid depletion 68 144 212 32.10
Lymphoedema 22 187 209 10.50
Lymphadenopathy 49 164 213 23
Macrophage syncytia 29 183 212 13.70
intracellular inclusion bodies 26 186 212 12.30
Focal necrosis 17 195 212 8
Kidney pathology 32 173 205 15.60
Respiratory pathology 132 103 235 56.20
Lung consolidation 94 123 217 43.30
Lung oedema 51 163 214 23.80
Broncho interstitial pneumonia (BP-BIP) 49 162 211 23.20
Enteric pathology 155 83 238 65.10
Peritonitis 24 185 209 11.50
Stomach ulcer (gut ulcer) 18 195 213 8.50
Abdominal fluid 19 193 212 9
Porcine dermatitis and nephropathy 
Syndrome (PDNS)
10 188 198 5.10
Rash 10 202 212 4.70
Organomegaly 10 202 212 4.70
Brain oedema 15 197 212 7.10
Meningitis 16 196 212 7.50
Pericardium pathology 37 175 212 17.50
Eye pathology 5 207 212 2.40
Aborted 4 208 212 1.90
TA B L E  4   Count of findings, signs and 
symptoms used in the latent class analysis
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BIC was at 3 latent classes, and for one, the model fit to symptoms 
occurring 20 times or more, the lowest BIC was for 4 latent classes. 
A veterinary expert opinion established a substantively meaning-
ful set of symptoms were those occurring ten times or more, for 
which 3 latent classes were the best fitting model. Our initial 
model (Figure 4, Supplementary Data S2) identified three groups 
of animals: those with predominantly respiratory symptoms, but 
no wasting, and fewer GI symptoms; those with a predominance 
of GI symptoms, and little respiratory symptoms and wasting; and 
a third group with prominent wasting, respiratory and gut symp-
toms. The ordering of these three groups is arbitrary within any 
given model.
To examine the effect of other covariates, specifically the age 
of the animal and evidence of viral infection, a series of latent class 
regression models were fitted with covariates representing the age 
group of the animal, and evidence of infection with PCV2 and PPV2-
PPV4 (Supplementary Data S2). Age and PCV2 did contribute to 
class membership, and there was little evidence of any contribution 
of PPV2, PPV3 or PPV4 on their own to class membership. However, 
there was good evidence for a joint effect of PCV2 and PPV2, and 
some evidence for an interaction between them (Table 6). Once both 
viruses were added to the model, there was little remaining evidence 
for an effect of age (Table 7). The confidence intervals for these ef-
fects are wide, reflecting the relatively small number of animals, but 
the direction and approximate magnitude of the main effects appear 
to be robust to a range of modelling assumptions.
3.5 | Phylogenetic analysis
The partial PPV2 variable region of the VP1 capsid gene sequence 
from 33 selected samples with low Ct values was determined 
and edited to a 330-bp fragment to incorporate the equivalent 
sequenced regions deposited in GenBank for phylogenetic anal-
ysis (Figure 5) (Saekhow & Ikeda, 2014). The ML tree displays 
two distinct clades inclusive of 81 sequences downloaded from 
GenBank and PPV2 sequences from this study with an overall nu-
cleotide percentage homology identity between the clades at 88 
to 96%. The p-distance within clade 1 was 0 to 0.08, clade 2 at 0 
to 0.06 and between clades p-distance of 0.04 to 0.13. The ma-
jority of PPV2 sequences in this study and dating from 1996 to 
2012 clustered in clade 2 comprising of mainly European samples 
with a 6% homology difference. Only three PPV2 sequences from 
this study (MK639161 isolate 5, MK639164 isolate 8, MK639169 
isolate 13), with nucleotide homology difference at 7%, and dating 
from 2004 and 2005, were positioned in the upper clade 1 with 
an assortment of sequence origins from South Korea (KY018938), 
USA (JX101461), China (MG345013), Brazil (KF725661) and other 
European countries. Wild boar sequences were situated in both 
clades of the PPV2 phylogenetic tree.
The complete viral capsid gene of 9 PPV3 UK samples with low 
Ct values was sequenced for phylogenetic analysis (Figure 6), situ-
ated at 2,180 to 4957bp on reference KY586145 PPV3 sequence 
and was aligned with an additional sixty full capsid sequences. The 
range of the nucleotide difference in the PPV3 phylogenetic tree 
was 5% across samples from both domestic pigs and wild boar orig-
inating from China, USA, South America and Europe creating three 
main clades with a p-distance between the clades of 0.01 to 0.05. 
The sequences from this study positioned within clade 3 (p-distance 
of 0 to 0.03) nearest to European nested clades. PPV3 MK649766 
isolate 16 from 2010 had the lowest nucleotide homology with the 
Chinese strain JQ177082 from clade 2 at 95%. The clades 1 and 2 
represent a small number of Chinese PPV3 sequences dating from 
2005 to 2007 and 2010 to 2011, respectively.
The nearly complete capsid sequences for 3 PPV4 isolates, at 
the position of 3,430 to 5308bp of reference sequence KC701334, 
were phylogenetically analysed (Figure 7). The PPV4 ML tree split 
into two clades with high genetic nucleotide homology of 97% to 
100% and nucleotide p-distance at 0.01 to 0.02. The PPV4 isolate 01 










PCV2 PPV2 1.88 1.03 3.46
PPV3 1.89 0.884 4.12
PPV4 5.65 1.68 24.5
PPV2 PCV2 1.91 1.06 3.48
PPV3 7.74 3.36 19.1
PPV4 1.28 0.448 3.55
PPV3 PCV2 1.86 0.854 4.15
PPV2 8.49 3.6 21.6
PPV4 2.21 0.564 7.13
PPV4 PCV2 6.24 1.95 25.3
PPV2 1.34 0.468 3.75
PPV3 2.42 0.619 7.78
TA B L E  5   Confidence interval
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2004 to 2011 whereas clade 2 sequences were of mixed global 
origins from China and Brazil with isolate 07 (MK613834) and 05 
(MK609919) nested within European clades.
Positive PCV2 samples (n = 50) were sequenced for PCV2 capsid 
open reading frame 2 in a parallel study revealing a genotype PCV2a 
shift to PCV2b occurring prior to the introduction of PCV2 vaccina-
tion (Collins & Zaykalova, 2020).
All sequences were deposited in NCBI GenBank with accession num-
bers; PPV2 MK639157-MK649760, PPV3 MK0649761-MK649769 
and PPV4 MK609918, MK609919 and MK613834.
4  | DISCUSSION
There is a scientific premise concerning pig herd health issues attrib-
uted to viral aetiology in cases of multi-factorial PCVAD and PRDC 
which remains unexplained (Opriessnig et al., 2011; Qin et al., 2018). 
Parvovirus plays an important role as a viral co-factor in PCVAD and 
PRDC, and with compounding factors of high nucleotide substitu-
tion rate, positive selection from vaccination pressure, co-infection 
and recombination all contribute to the continual adaption and 
emergence of new parvovirus strains (Parrish & Kawaoka, 2005; 
F I G U R E  3   Count of reported symptoms, signs and findings per study Count of reported symptoms, signs and findings for each of the 
four studies that recorded a range of symptoms and physical findings on post-mortem, the number of occasions on which each was recorded
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Shackelton & Holmes, 2006). The current study cohort represented 
clinically diseased animals from a range of production age groups, 
with samples dating from 1997 to 2012 of which 65% were acquired 
prior to the introduction of the PCV2 vaccine in ~2006. PPV2-PPV4 
were found to exhibit similar infection prevalence profiles in pre-
weaner (2%, 3% and 1%) and weaner (11%, 3% and 2%) age groups, 
F I G U R E  4   Latent class model membership probabilities. The estimated probability from the base latent class model which a particular 
symptom, sign or finding occurs amongst the members of each of the three latent classes occurs. Symptoms, signs and findings are ordered 
in terms of their overall frequency across the whole study sample
TA B L E  6   Covariates of PPV2 and PCV2
Term Class Value coefficient Value standard error
Odds 
ratio Odds ratio lower
Odds ratio 
upper
Intercept Class 2:1 0.58 0.41
PCV2 count Class 2:1 1.19 0.77 3.28 0.73 14.9
PPV2 count Class 2:1 −0.29 0.91 0.75 0.13 4.41
PCV2 count.PPV2 count Class 2:1 −2.06 1.24 0.13 0.01 1.45
Intercept Class 3:1 −1.88 0.89
PCV2 count Class 3:1 3.78 1.09 43.7 5.14 370
PPV2 count Class 3:1 1.49 1.3 4.45 0.34 57.4
PCV2 count.PPV2 count Class 3:1 −3.17 1.48 0.04 0 0.77
TA B L E  7   Covariates of PCV2 and PPV2 with age
Term Class Value coefficient Value standard error
Odds 
ratio Odds ratio lower
Odds ratio 
upper
Intercept Class 2:1 −3.89 1.67
PCV2 count Class 2:1 2.21 1 9.11 1.28 64.9
PPV2 count Class 2:1 0.26 0.68 1.3 0.34 4.91
Ages Class 2:1 0.79 0.5 2.21 0.83 5.88
Intercept Class 3:1 −2.27 1.29
PCV2 count Class 3:1 −0.52 0.61 0.59 0.18 1.96
PPV2 count Class 3:1 0.83 0.87 2.3 0.42 12.6
Ages Class 3:1 0.68 0.56 1.98 0.67 5.87
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MK639163 PPV2 (07) UK 2004 D.P
MK639162 PPV2 (06) UK 2010 D.P
KC701310 Hungary 2007 D.P
AB973330 Thailand 2011 D.P
KC701291 Croatia 2006 D.P
KP765690 Hungary 2013 D.P
MK649742 PPV2 (17) UK 2004 D.P
KC767891 Poland 2011 D.P
KF725662 USA 1998 D.P
MH778962 South Korea 2018 D.P
MK649753 PPV2 (28) UK 2010 D.P
KC701314 Poland 2011 D.P
MK649746 PPV2 (21) UK 2002 D.P
MK649754 PPV2 (29) UK 2010 D.P
KC701303 Poland 2011 D.P
AB973334 Thailand 2011 D.P
KC687097 Poland 2011 D.P
AB973328 Thailand 2011 D.P
JQ860241 Romania 2010 D.P
KC687099 Croatia 2009 D.P
AB973322 Thailand 2011 D.P
KC701304 Serbia 2011 D.P
AB973329 Thailand 2011 D.P
MG345016 China 2018 D.P
MK639161 PPV2 (05) UK 2005 D.P
MG345013 China 2018 D.P
MK639160 PPV2 (03) UK 2005 D.P
AB973325 Thailand 2011 D.P
JQ860244 Romania 2009 W.B
MK649757 PPV2 (32) UK 2012 D.P
KC701307 Croatia 2008 D.P
AB973319 Thailand 2011 D.P
MK649751 PPV2 (26) UK 2005 D.P
MG345015 China 2018 D.P
KC701301 Poland 2011 D.P
MK649760 PPV2 (15) UK 2004 D.P
MK649743 PPV2 (18) UK 2010 D.P
JQ860243 Romania 2009 W.B
MK639170 PPV2 (14) UK 2004 D.P
AB973331 Thailand 2011 D.P
KM926355 Brazil 2011 D.P
AB973317 Thailand 2011 D.P
KC701305 Serbia 2011 D.P
JQ860238 Romania 2010 D.P
KC701299 Poland 2011 D.P
KC701312 Serbia 2008 D.P
MK649758 PPV2 (33) UK 1996 D.P
MK649749 PPV2 (24) UK 2002 D.P
AB973315 Thailand 2011 D.P
AB973321 Thailand 2011 D.P
MH778963 South Korea 2018 D.P
KC701298 Hungary 2007 D.P
AB973318 Thailand 2011 D.P
KC701302 Poland 2011 D.P
KC701308 Croatia 2011 D.P
JQ860240 Romania 2010 D.P
KC701297 Serbia 2008 D.P
MK639158 PPV2 (02) UK 1998 D.P
KY018935 South Korea 2016 D.P
JX101461 USA 2011 D.P
MG345017 China 2018 D.P
JQ860239 Romania 2010 D.P
JQ860242 Romania 2010 D.P
MK649748 PPV2 (23) UK 2002 D.P
KC701293 Serbia 2011 D.P
MK639164 PPV2 (08) UK 2004 D.P
KC701311 Hungary 2007 D.P
AB973316 Thailand 2011 D.P
KU745627 China 2015 D.P
MK649759 PPV2 (16) UK 2004 D.P
AB973332 Thailand 2011 D.P
KC701296 Hungary 2009 D.P
MK649744 PPV2 (19) UK 2010 D.P
JX101462 USA 2011 D.P
AB973324 Thailand 2011 D.P
KF725661 Brazil 2012 D.P
KC701306 Serbia 2007 D.P
MK639159 PPV2 (04) UK 2010 D.P
NC 025965 Brazil 2011 D.P
MK649750 PPV2 (25) UK 2002 D.P
MK649752 PPV2 (27) UK 2010 D.P
AB973320 Thailand 2011 D.P
MK649745 PPV2 (20) UK 2010 D.P
MK639157 PPV2 (01) UK 2002 D.P
MK639166 PPV2 (10) UK 2010 D.P
KY018936 South Korea 2016 D.P
AB973333 Thailand 2011 D.P
KC767891 Poland 2011 D.P
JQ860248 Romania 2009 W.B
MK649755 PPV2 (30) UK 2010 D.P
MK649756 PPV2 (31) UK 2010 D.P
JQ860245 Romania 2009 W.B
MK639167 PPV2 (11) UK 2005 D.P
KC701300 Hungary 2009 D.P
KC687098 Croatia 2011 D.P
KC701294 Serbia 2011 D.P
MK639169 PPV2 (13) UK 2004 D.P
MK649747 PPV2 (22) UK 2002 D.P
AB973326 Thailand 2011 D.P
MK639168 PPV2 (12) UK 2004 D.P
AB973323 Thailand 2011 D.P
KC701295 Poland 2011 D.P
MG345018 China 2018 D.P
AB973327 Thailand 2011 D.P
KC701309 Poland 2011 D.P
JQ860247 Romania 2009 W.B
KC701313 Serbia 2008 D.P
MG345014 China 2018 D.P
AB916464 Japan 2010 D.P
KY586144 Brazil 2008 D.P
JQ860246 Romania 2009 W.B
MG345019 China 2018 D.P
KC701292 Serbia 2007 D.P
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whilst fattener (>10 weeks) group profiles demonstrated higher lev-
els of PPV2 (56%, 14% and 9%), signifying PPV2 to be the most prev-
alent novel PPV in this study. In contrast, PCV2 had a high level of 
prevalence at foetus level (36%) through vertical transmission which 
dipped at the pre-weaner age due to maternal antibody and/or vac-
cine effects, and which then increased to 61% and 77% in weaner 
and fattener groups, respectively. Statistical analysis in diseased pigs 
demonstrated the presence of PPV2 and PPV4 in pigs with lung dis-
ease and lymph node oedema pathologies. PPV2 detection signifi-
cantly identified in pigs with pneumonia and BIP, whilst PPV4 was 
more specifically associated with lung oedema. However, although 
no statistical association of PPV2-4 and PCVAD wasting symptoms 
was identified, all had significant association with enteric ulcers with 
PPV2 and PPV3 significantly associated with peritonitis. Veterinary 
clinical scored data composed of 25 parameters from the diseased 
pig cohort were also applied to the detection of novel parvoviruses 
(PPV2-PPV4) utilizing LCA, indicating that PCV2 and PPV2 cluster-
ing, as a concurrent infection, was observed as significantly associ-
ated. Moreover, this analysis also found that no statistical significant 
association with PCVAD could be drawn from single viral infections 
or other combinations apart from PPV2 and PCV2. This observed 
PCV2 and PPV2 co-infection confirms findings from other studies 
using different statistical approaches (Opriessnig et al., 2013, 2014; 
Saekhow & Ikeda, 2014).
The observed concurrent infections of novel PPV and 
PCV2 resulted in PCV2 and PPV2 being the most predominant 
(12.9%), whilst other co-infections occurred at a much lower 
rate (<3.6%) similar to findings from a previous reported USA 
study (Opriessnig et al., 2014), with the viral distribution across 
age groups also similar to previous reports (Cságola et al., 2012; 
Xiao, Gerber, et al., 2013; Xiao et al., 2012). The low-level prev-
alence of novel PPVs in the pre-weaner and weaner age groups 
may indicate that the viruses were not vertically transmitted or 
that piglets acquired protection from maternally derived antibody 
and is comparable to the epidemiological serological profile study 
of PPV2 infection with severe respiratory disease, where onset 
occurred from 28 days post-decline of PPV2 protective mater-
nal antibodies (Cságola et al., 2016). A subset of samples (10%) 
from this cohort were initially screened for PPV1 resulting in neg-
ative or very weakly positive results, with remaining samples not 
tested considering that the widely administered PPV1 vaccine 
would result in low prevalence. The most recent European PPV 
prevalence studies undertaken in Poland (2015–2017) on 19 pig 
farms detecting PPV1-6 genotypes reported a high prevalence of 
PPV2 (69%), PPV5 (28%) and PPV6 (32%) in sera with lower levels 
of PPV3 and PPV4, and due to vaccination a very low level of 
PPV1 notably, however, oral fluid levels detected higher levels 
of virus (Miłek et al., 2019). A study on 8 farms with non-acute 
PCVAD pig serum samples (2014–2017) reported a significant 
higher level of PCV2 virus detected when co-infected with PPV7 
(Miłek et al., 2020). Assessments of the prevalence of novel PPVs 
and correlation to PCV2 genotypes showed a high prevalence of 
PPV2 occurring where the vaccine evading PCV2d genotype was 
detected (Opriessnig et al., 2014). Parallel analysis of this sample 
cohort detected only PCV2a and PCV2b genotypes, with PCV2b 
being the dominant strain from 2003 onwards whilst other PCV2 
genotypes were not detected (Collins & Zaykalova, 2020). The 
global prevalence rates of novel PPVs are considerably variable, 
specifically the prevalence of PPV3 and PPV4 virus, and this vari-
ation is compounded by factors not fully understood and may af-
fect the viral epidemiological dynamics, for example the country 
of origin, sample type, study design, environmental factors and 
year of sampling. A recent retrospective study (Sun et al., 2015) 
on PCVAD suspected pigs (mixed samples) in China revealed a 
similarly higher occurrence of PPV3 (45.11%) and PPV4 (21.56%), 
with a South African prevalence study of healthy and sick pigs 
(2015–2016) reporting a higher rate of PPV4 prevalence (43.6%) 
(Afolabi et al., 2018). Whilst these recent reports are indicative 
that prevalence rates for PPV3 and PPV4 may have increased, val-
idated standardized assays, phylogenetic analysis, sample age and 
tissue type would be beneficial in enabling data comparisons to 
be made from any future studies.
The retrospective yearly virus prevalence, first detected PCV2 
in 1998, and whilst profiling a high prevalence, a decline in fre-
quency occurred with the introduction of the PCV2 vaccine (~2006) 
(Table 1, Figure S5). The impact of vaccine reduced the PCV2 fre-
quency, which continued over several years, followed by a yearly 
incline of prevalence from 2009 onwards to 2012. The most con-
sistently present novel PPV, PPV2, detection occurs years from 
1998 to 2012; however, all novel PPV2-4 were undetectable from 
2006 to 2008. The correlation of novel PPV absence is possibly 
linked with the PCV2 vaccine introduction and impact of reduc-
tion of PCV2 frequency (Table 1, Figure S5). It is well established 
that the suppression of the immune system by PPV1 co-infection 
allows the increases PCV2 viral replication and hence greater viral 
load, conversely, the presence of virus per year has highlighted, that 
PCV2 may also be essential for the interdependent existence of the 
novel PPV’s warranting further investigations. The PCV2 and PPV2 
F I G U R E  5   PPV2 phylogenetic analysis. The tree with the highest log-likelihood (−2324.94) is shown and analysis involved 114 nucleotide 
sequences. There were a total of 330 positions in the final data set and formed two main clades. Figures 5 to 7 phylogenetic analysis. The 
molecular phylogenetic analysis by maximum-likelihood method for PPV2-PPV4 virus's evolutionary history was inferred by using the 
maximum-likelihood method based on the Tamura-Nei model (Tamura & Nei, 1993). Initial tree(s) for the heuristic search were obtained 
automatically by applying neighbour-join and BioNJ algorithms to a matrix of pairwise distances estimated using the maximum composite 
likelihood (MCL) approach, obtaining 1,000 bootstrap replicates and then selecting the topology with superior log-likelihood value. The tree 
is drawn to scale, with branch lengths measured in the number of substitutions per site. Evolutionary analyses were conducted in MEGA X 
(Kumar et al., 2018)
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in this study detected virus from 1998 although an additional PPV2 
sample was sequenced from 1996 and included in the phylogenetic 
sequencing analysis which may be the earliest reported detection. 
A previous retrospective study established PCV2 circulated in pig 
herds since 1962 and before the observation of clinical PMWS 
cases, and in the USA a study detected the PCV2 in 1998 (Jacobsen 
F I G U R E  6   PPV3 phylogenetic analysis. The tree with the highest log-likelihood (−10311.93) is shown and analysis involved 69 
nucleotide sequences. There were a total of 2,787 positions in the final data set and formed three clades
KC701332 Serbia 2007 D.P
KX827772 China 2015 D.P
JQ868700 Romania 2010 D.P
KX827776 China 2015 D.P
JF738350 Romaina 2007 W.B
EU200673 China 2005-2007 D.P
MK649761 PPV3 (01) UK 2004 D.P
MK649769 PPV3 (22) UK 2010 D.P
EU200671 China 2005-2007 D.P
MK649765 PPV3 (17) UK 2010 D.P
JQ177080 China 2010 D.P
JF738368 Romaina 2010 W.B
EU200675 China 2005-2007 D.P
KX827777 China 2015 D.P
KC701328 Serbia 2007 D.P
KC701321 Serbia 2008 D.P
JQ177079 China 2011 D.P
KC701331 Poland 2011 D.P
KU167029 China 2015 D.P
JQ425257 USA 2011 D.P
EU200674 China 2005-2007 D.P
EU200672 China 2005-2007 D.P
MK649764 PPV3 (16) UK 2010 D.P
KC701319 Hungary 2008 D.P
KX827774 China 2015 D.P
KX827775 China 2015 D.P
EU200676 China 2005-2007 D.P
KC701326 Hungary 2008 D.P
JQ868701 Romania 2010 D.P
KC701323 Croatia 2009 D.P
JQ868703 Romania 2010 D.P
MK649762 PPV3 (02) UK 2002 D.P
JQ868705 Romania 2010 D.P
KC701316 Serbia 2011 D.P
KU167028 China 2015 D.P
MG345026 China 2016 D.P
KF561853 USA 1998 D.P
JF738362 Romaina 2010 W.B
KC701325 Hungary 2008 D.P
KY586145 Brazil 2008 D.P
MK649768 PPV3 (21) UK 2010 D.P
KF561854 USA 1998 D.P
EU200677 China 2005-2007 D.P
JQ177081 China 2011 D.P
KC701324 Hungary 2008 D.P
JQ177082 China 2011 D.P
JQ177078 China 2011 D.P
JQ868706 Romania 2010 D.P
JF738367 Romaina 2010 W.B
KC701320 Croatia 2008 D.P
KC701330 Serbia 2008 D.P
KC701329 Serbia 2008 D.P
JQ868704 Romania 2010 D.P
JF738364 Romaina 2010 W.B
JQ868702 Romania 2010 D.P
KC701318 Croatia 2010 D.P
MK649763 PPV3 (03) UK 2002 D.P
JF738351 Romaina 2007 W.B
KC701327 Hungary 2008 D.P
MK649766 PPV3 (18) UK 2010 D.P
JQ177083 China 2010 D.P
MK649767 PPV3 (19) UK 2010 D.P
JF738357 Romaina 2010 W.B
JF738366 Romaina 2011 W.B
KX827773 China 2015 D.P
JQ868699 Romania 2010 D.P
KC701315 Croatia 2008 D.P
KC701322 Croatia 2011 D.P
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et al., 2009; Opriessnig et al., 2014). Both PPV3 and PPV4 were only 
detected from 2000 and are earlier than they were originally dis-
covered although a previous study identified PPV3 in USA in 1998 
whereas this may be the earliest reporting of PPV4.
Empirically, tissue sampled from a variety of sample types 
allowed for an insight into the tropism of these viruses with an 
overall prevalence of PCV2 (47%), PPV2 (17.3%), PPV3 (5.8%) and 
PPV4 (3.5%). PPV2 to 4 caused systematic infection in pigs with 
virus detected mainly in the lymphatic tissue, lungs, nasal tract, 
faeces and sera. Subsequent analysis showed that the lung tissue 
prevalence of PPV2 was high (28%) although PCV2 had the high-
est prevalence (45%). In the current study, bronchial and medias-
tinal lymph nodes situated near the respiratory system were only 
positive for PPV2 which supports evidence that PPV2 is involved 
in respiratory infection. PPV2 to 4 were found in a kidney sample 
tested meriting further investigation to better understand the role 
of PPV2-4 in kidney pathology and disease. It was also observed 
that PPV2 was detected at a much higher rate in lymphatic tissue 
such as tonsil (28%), spleen (43%), mesenteric LN (30%), medi-
astinal LN (29%), inguinal LN (52%) and bronchial LN (33%) than 
PPV3 and PPV4, indicating that in this cohort PPV2 is more viru-
lent and better adapted to cause systemic infection. A USA study 
reported lung tissue prevalence of PPV2 (42.7%), PPV3 (9.1%) and 
PPV4 (4.3%) (Opriessnig et al., 2014) whereas a Japanese study 
in both clinically diseased and healthy slaughter age pigs’ tonsils 
found elevated PPV2 prevalence of 100% and 58%, respectively 
F I G U R E  7   PPV4 phylogenetic analysis. The tree with the highest log-likelihood (−4422.01) is shown. The analysis involved 49 
nucleotide sequences, and there were a total of 1731 positions in the final data set formed two clades
HM031135 China 2009 D.P
KC701352 Romania 2010 D.P
KC701337 Poland 2011 D.P
MK609918 PPV4 (01) 2004 D.P
GQ387500 USA 2006 D.P
KC701344 Croatia 2008 D.P
KC701349 Hungary 2007 D.P
KC701342 Hungary 2007 D.P
GU978968 China 2009 D.P
GU978965 China 2009 D.P
JQ868707 Romania 2007 D.P
KC701350 Poland 2011 D.P
KC701333 Poland 2011 D.P
GU978967 China 2009 D.P
KC701341 Hungary 2007 D.P
KC701356 Serbia 2007 D.P
KC701354 Serbia 2007 D.P
KC701355 Poland 2011 D.P
JQ868715 Romania 2007 W.B
HM031134 China 2009 D.P
KC701343 Hungary 2008 D.P
MK613834 PPV4 (07) 2002 D.P
JQ868712 Rominia 2007 W.B
MG345027 China 2017 D.P
'KC701347 Poland 2011 D.P'
KC701346 Hungary 2008 D.P
GU978966 China 2009 D.P
JQ868711 Romania 2007 D.P
JQ868710 Romania 2010 D.P
KY586146 Brazil 2008 D.P
KC701336 Poland 2011 D.P
JQ868713 Romania 2007 W.B
KC701351 Serbia 2007 D.P
MK609919 PPV4 (05) 2004 D.P
KC701353 Serbia 2007 D.P
JQ868708 Romania 2010 D.P
KC701345 Serbia 2008 D.P
KC701338 Serbia 2006 D.P
NC014665 USA 2006 D.P
KC701340 Hungary 2007 D.P
KC701335 Poland 2011 D.P
KC701348 Serbia 2011 D.P
JQ868714 Romania 2007 W.B
KC701339 Hungary 2007 D.P
GU978964 China 2009 D.P
JQ868709 Romania 2010 D.P
JQ868716 Romania 2007 W.B
GQ387499 USA 2006 D.P
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(Saekhow & Ikeda, 2014). A 2010 German study of hearts and ton-
sils of slaughter age pigs detected PPV2 in 55% of tonsils and 78% 
of hearts, with PPV3 and PPV4 detected at lower rates in tonsils 
only (Streck et al., 2013). This prevalence level demonstrated that 
the PPV2 virus could exist at subclinical levels in relatively healthy 
pigs, with lymphatic and heart tissue targeted by PPV2 particularly 
as parvovirus is known to favour mitotically active cells that enter 
the S-phase for their replication. Recent fundamental pathogene-
sis studies on PPV2 have provided further crucial information on 
viral tropism and infection dynamics. The pathology of PCV2 and 
PPV2 infection indicated that PPV2 may contribute to the pathol-
ogies of pneumonia observing significant association with lung 
lesions (Novosel et al., 2018). Opriessnig (2016) performed an ex-
perimental infection of PCV2 and PPV2 (via a tissue homogenate) 
finding infected pigs developed microscopic lesions with severe 
lymphoid depletion, consistent with PCVAD, demonstrating that 
PPV2 can act as the trigger for PCVAD in the presence of PCV2 
infection.
Phylogenetic analysis of novel PPVs in this study showed the 
greatest genetic diversity occurred within PPV2 sequences where 114 
PPV2 sequences of global origin from both domestic and wild boar 
formed two distinct clades as reported previously (Figure 5) (Cságola 
et al., 2012; Saekhow & Ikeda, 2014). A high nucleotide divergence of 
88 to 96% with a p-distance of 0.04 to 0.13 between each clade in this 
study was determined. The VP1 PPV2 gene is a potential genotype 
subtyping region with a cut-off p-distance value of 0.04. Clade 1 se-
quences were comprised of chronologically more recent (up to 2018) 
PPV2 isolates, although it also included three early sequences isolated 
in this study (from 2004 and 2005 samples) demonstrating continual 
evolution and adaption of the PPV2 capsid. The evolutionary diversity 
of PPV2 capsid region mutations resulting from antigenic escape, host 
adaption or the role of viral pathogenicity remains to be established 
and highlights the need to continue to phylogenetically map current 
circulating strains assessing the divergence of the PPV2 clade 1. The 
PPV3 phylogeny maps three main clades with the majority of strains 
positioned within clade 3 originating from global strains although 
predominantly strains isolated from Europe. The clades 1 and 2 com-
prise of PPV3 strains from China isolated in 2007 to 2011 showing 
further divergence of PPV3 with an overall nucleotide homology 
difference of 5% across all clades. The PPV3 strains from this study 
are nested clades within clade 3 with the most similar strains to the 
European strains, including wild boar although one sequence mapped 
more closely to a USA strain from 1998 (Figure 6). The PPV4 capsid 
remains highly conserved in comparison with PPV2 (Cadar, Csagola, 
et al., 2013; Cadar, Lorincz, et al., 2013) with a high 97% nucleotide 
homology similarity. It would be advantageous to phylogenetically 
map more recently isolated PPV2, PPV3 and PPV4 viruses to ascer-
tain whether further genetic drifting or recombination has occurred.
The findings of this study on clinically diseased pigs have 
demonstrated that PPV2, a genetically diverse virus, is a co-factor 
to PCV2 infection in PCVAD and PRDC. In the absence of iso-
lated and cultured virus, statistical modelling by LCA analysis has 
indicated that cluster co-infection of PPV2 and PCV2 occurs in 
a diseased pig population, whereas PPV3 and PPV4 showed no 
cluster association with PCV2. Further investigations establishing 
viruses attributed to PRDC disease utilizing quantifiable PCR as-
says for viral load and including PPV5 to PPV7, PCV3 plus porcine 
bocaparvoviruses would be beneficial. Additionally, inclusion of 
swine influenza, an important primary pathogen of PRDC and a 
causative agent of lung lesions, should be considered as a critical 
parameter in statistical modelling analysis. Future work by viral 
metagenomics in longitudinal studies is an advantageous tool in 
understanding disease associations, co-infection dynamics of par-
voviruses and PRDC. Successful viral isolation/propagation and 
the development of serological neutralization assays for PPV2-7 
will be necessary in order to determine Koch's postulates, and 
characterize viral serotypes and cross-protection with the ulti-
mate aim of developing a suitable vaccine candidate with good 
antigenic variability to protect pig herds. This study confirms the 
novel PPV 2–4 virus's co-infection occurs with PCV2 and can be 
statistically associated with respiratory disease and specifically, 
PPV2 co-infects with PCV2 in PRDC and PCVAD.
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